Follow up analysis of the breaches to the US FDA OPDP regulations by Pharma, looking at the reasons why and digital channels employed. Do Pharma really have an issue using digital from a compliance perspective?
How to respond to what healthcare professionals are telling us?Agnitio
Between 25 June and 18 July 2014, Agnitio ran a survey to discover how well the industry is responding to healthcare professionals’ needs. The survey included an expert panel discussion and a questionnaire in which 192 professionals took part.
Understanding Patient opinion leaders in social mediaAmit Srivastava
This presentation takes a deep dive into patient opinion leader behavior in social media. It also show cases ways to incubate social media leaders rather than hiring expensive POLs.
As the global biosimilars market opens up, what do physicians faced with choosing between prescribing a brand-name biologic or biosimilar think – and know?
Proactive patient engagement can lead to lower cost of care and better outcomes. Giving patients the tools to keep track of care outside of the doctor’s office makes it easier for them to adhere to their care plan and stay on the path to better outcomes
Overview of the Health B2B2C Ecosystem; Use Social Media as a Market Focus Tool; Measure Your Performance; American Health Insurance Reality; Lack of Doctor Relationship; PR is the New Primary Care Facilitator; For Health Marketers – End-users Matter; Innovation drives healthcare advances; Ways to Improve Health and Make Money; Medicine Is a Team Sport; Big Data- Allowing Individual Patients to Leverage The Many; Some Examples of What Works- Equashield, EarlySense, MD Anderson, LifePoint; 3D Systems; American Association for Cancer Research,
How to respond to what healthcare professionals are telling us?Agnitio
Between 25 June and 18 July 2014, Agnitio ran a survey to discover how well the industry is responding to healthcare professionals’ needs. The survey included an expert panel discussion and a questionnaire in which 192 professionals took part.
Understanding Patient opinion leaders in social mediaAmit Srivastava
This presentation takes a deep dive into patient opinion leader behavior in social media. It also show cases ways to incubate social media leaders rather than hiring expensive POLs.
As the global biosimilars market opens up, what do physicians faced with choosing between prescribing a brand-name biologic or biosimilar think – and know?
Proactive patient engagement can lead to lower cost of care and better outcomes. Giving patients the tools to keep track of care outside of the doctor’s office makes it easier for them to adhere to their care plan and stay on the path to better outcomes
Overview of the Health B2B2C Ecosystem; Use Social Media as a Market Focus Tool; Measure Your Performance; American Health Insurance Reality; Lack of Doctor Relationship; PR is the New Primary Care Facilitator; For Health Marketers – End-users Matter; Innovation drives healthcare advances; Ways to Improve Health and Make Money; Medicine Is a Team Sport; Big Data- Allowing Individual Patients to Leverage The Many; Some Examples of What Works- Equashield, EarlySense, MD Anderson, LifePoint; 3D Systems; American Association for Cancer Research,
Growing Bio-pharma Digital Marketing Impact by Digitizing Launch, Developing ...Best Practices
It has become quite crucial to identify the drivers of digital marketing performance excellence in the health care industry which will enable companies to gain valuable customer insights, build effective relationships, leverage online media, and maximize revenue.
Best Practices, LLC undertook this benchmarking research to provide critical insights into how savvy bio-pharma digital marketers are enhancing the medical and commercial potential of new products, improving alignment with brand teams, acquiring and training new digital marketers, managing service delivery for key programs and optimizing insource vs. outsource mix.
Download Full Report: http://bit.ly/2gnXrIu
7 Big Physician and Patient Engagement Trends You Can’t Miss for Brand PlanningDRG Digital
Pharma's customers, media, technology, and the healthcare landscape have evolved tremendously over the past year – with new opportunities and threats that will impact every healthcare marketers’ brand planning.
Which opportunities and threats are most significant? How can you best position your brand for success in today’s new marketing reality?
DRG Digital Senior VP Meredith Ressi distills a year’s worth of research and news into a concise webinar that will help strengthen your brand planning:
- Seven big physician and patient engagement trends you can’t miss for 2017 brand planning
- Key data sources you need to be better informed about your patients and physicians
- Practical framework for determining the right channels, media and content for your audience
- Resources and tips you can share with your organization
5 ways to succeed with digital pharma marketingJo Peddhinti
Go beyond your average webinars and banner ads. Discover innovative ways to improve your digital marketing strategy. Set your brand apart from competition and improve your ROI.
Digital marketing in pharma - trends and way aheadRanajay Sengupta
This presentation captures the trends in the Pharma Marketing today and how digital is shaping consumer behaviour, brand awareness and customer pull. This also includes the areas where Pharma companies should focus in the new era to successfully leverage the potential of digital
e-detailing: effective promotion of professional science communication Merqurio
The evolution of new information and communication technologies (ICT) has designed an innovative model to transmit data in the healthcare field.
This model can support the health care and administrative processes of companies, management of the relationship between patients and facilities and, lastly, medical and scientific information.
Pharma Digital Marketing - 5 future trendsmarcmunch2014
Digital Marketing within the Pharma Industry:
The first and safer way is to summarize the past 12 months, the second, more dangerous but also more exciting is to predict what will happen in 2015.
For years digital marketing was treated as a fifth wheel in pharma business. Whatever we say, the truth is that those organisations are made of sales force. And a digital sales force was just another marketing gimmick that does not add value but a workload and cost.
However, during past few years this traditional sales force thinking was challenged. Payers pressure forced companies to reduce ranks of sales representatives. Regulatory decisions have limited possibility of sales rep to meet HCPs. The result is that sales rep cannot meet his Client often enough to detail the product and maintain relationship in the same time.
Digital came to help with e-detailing and web-based self-detail solutions. CRM software supports reps with data that allow reps to have a meaningful conversation with HCPs they barely know.
Combining detailing visits with digital tatics and good old direct marketing is our new buzz word: Multi Channel Marketing or Multi Channel Sales
Digital Content for Physicians in Global MarketsDRG Digital
Overview of emerging trends in physician digital behavior and engagement opportunities across 22 global markets in Latin America, Asia Pacific, the Middle East, and other emerging markets.
• Partnerships with local publishers to distribute content
• Social networks as a critical physician resource
• Demand for patient-oriented and value-added information and services in the evolving healthcare ecosystem
Digital Pharma: Evolution and Revolution in Marketing & SalesLen Starnes
A review for non-pharma audiences of evolutionary and revolutionary changes in pharma marketing and sales since the mid 90s. Presented at ENG's Effective Web Marketing and Search Engine Marketing conference, Brussels, November, 2007.
Collaborative Digital Pharma Marketing: A Role Model for Asia Pacific Healthc...Len Starnes
Presentation first given 10th March 2011 in Singapore at the Campaign Spotlight 'From Drugs to Brands' conference. Reviews the potential of collaborative marketIng in the Asia Pacific region with focus on physicians and patients.
Growing Bio-pharma Digital Marketing Impact by Digitizing Launch, Developing ...Best Practices
It has become quite crucial to identify the drivers of digital marketing performance excellence in the health care industry which will enable companies to gain valuable customer insights, build effective relationships, leverage online media, and maximize revenue.
Best Practices, LLC undertook this benchmarking research to provide critical insights into how savvy bio-pharma digital marketers are enhancing the medical and commercial potential of new products, improving alignment with brand teams, acquiring and training new digital marketers, managing service delivery for key programs and optimizing insource vs. outsource mix.
Download Full Report: http://bit.ly/2gnXrIu
7 Big Physician and Patient Engagement Trends You Can’t Miss for Brand PlanningDRG Digital
Pharma's customers, media, technology, and the healthcare landscape have evolved tremendously over the past year – with new opportunities and threats that will impact every healthcare marketers’ brand planning.
Which opportunities and threats are most significant? How can you best position your brand for success in today’s new marketing reality?
DRG Digital Senior VP Meredith Ressi distills a year’s worth of research and news into a concise webinar that will help strengthen your brand planning:
- Seven big physician and patient engagement trends you can’t miss for 2017 brand planning
- Key data sources you need to be better informed about your patients and physicians
- Practical framework for determining the right channels, media and content for your audience
- Resources and tips you can share with your organization
5 ways to succeed with digital pharma marketingJo Peddhinti
Go beyond your average webinars and banner ads. Discover innovative ways to improve your digital marketing strategy. Set your brand apart from competition and improve your ROI.
Digital marketing in pharma - trends and way aheadRanajay Sengupta
This presentation captures the trends in the Pharma Marketing today and how digital is shaping consumer behaviour, brand awareness and customer pull. This also includes the areas where Pharma companies should focus in the new era to successfully leverage the potential of digital
e-detailing: effective promotion of professional science communication Merqurio
The evolution of new information and communication technologies (ICT) has designed an innovative model to transmit data in the healthcare field.
This model can support the health care and administrative processes of companies, management of the relationship between patients and facilities and, lastly, medical and scientific information.
Pharma Digital Marketing - 5 future trendsmarcmunch2014
Digital Marketing within the Pharma Industry:
The first and safer way is to summarize the past 12 months, the second, more dangerous but also more exciting is to predict what will happen in 2015.
For years digital marketing was treated as a fifth wheel in pharma business. Whatever we say, the truth is that those organisations are made of sales force. And a digital sales force was just another marketing gimmick that does not add value but a workload and cost.
However, during past few years this traditional sales force thinking was challenged. Payers pressure forced companies to reduce ranks of sales representatives. Regulatory decisions have limited possibility of sales rep to meet HCPs. The result is that sales rep cannot meet his Client often enough to detail the product and maintain relationship in the same time.
Digital came to help with e-detailing and web-based self-detail solutions. CRM software supports reps with data that allow reps to have a meaningful conversation with HCPs they barely know.
Combining detailing visits with digital tatics and good old direct marketing is our new buzz word: Multi Channel Marketing or Multi Channel Sales
Digital Content for Physicians in Global MarketsDRG Digital
Overview of emerging trends in physician digital behavior and engagement opportunities across 22 global markets in Latin America, Asia Pacific, the Middle East, and other emerging markets.
• Partnerships with local publishers to distribute content
• Social networks as a critical physician resource
• Demand for patient-oriented and value-added information and services in the evolving healthcare ecosystem
Digital Pharma: Evolution and Revolution in Marketing & SalesLen Starnes
A review for non-pharma audiences of evolutionary and revolutionary changes in pharma marketing and sales since the mid 90s. Presented at ENG's Effective Web Marketing and Search Engine Marketing conference, Brussels, November, 2007.
Collaborative Digital Pharma Marketing: A Role Model for Asia Pacific Healthc...Len Starnes
Presentation first given 10th March 2011 in Singapore at the Campaign Spotlight 'From Drugs to Brands' conference. Reviews the potential of collaborative marketIng in the Asia Pacific region with focus on physicians and patients.
Companies can leverage social media to drive business and compete effectively in the new era of health care. But what do you need to know before jumping in or expanding your efforts? What considerations do medical technology marketing professionals need to take into account when implementing a strategic social-media plan?
Part one of our five-part series outlines how medical technology professionals can use social media in a regulated environment. Even more importantly, it gives readers the supporting evidence needed to recommend specific social-media strategies to management and internal legal and regulatory teams.
Healthcare is undergoing a transformation. Consumers want to make informed choices and take control of their lives, and pharma companies must be ready to meet their needs. This means building a new healthcare ecosystem that places the patient at its center, with the “person” fully engaged in his or her own healthcare. But with this move to person-centric healthcare, payers and providers are no longer the main decision makers.
So what does this mean for today’s marketers?
In this exclusive Social On Us webinar we discuss:
- Where marketing is failing to address healthcare concerns
- How “big data” is a change-driver for a new healthcare ecosystem
- New opportunities for predictive and preventative medical intervention
- Impact of digital healthcare on patient privacy
Social Media and Health Care: A Global PerspectiveSpectrum
On January 27, 2010, Spectrum and Aurora presented a PRSA webinar on how to leverage social media in a regulated industry.
It is important for the health care industry to begin 2010 with a clear vision for embracing social media. In 2009, health care regulators finally started to address the issue - from the FDA's public hearings to the creation of a digital marketing working group by the UK's Pharmaceutical Marketing Society. There is no denying that consumers are constantly turning to the Internet as a source for health information. As communications professionals, we need to understand the opportunities, challenges and threats of the emerging digital world.
Across Health Multichannel Barometer 2014Across Health
Across Health 2014 Multichannel Barometer survey shows Pharma’s painful progress towards digital productivity.
The 2014 Multichannel Barometer survey from Across Health paints a picture of a Life Sciences industry still struggling to come to terms with the realities of multichannel marketing.
The survey, now in its sixth year, shows digital spend plateauing compared with 2013 (15.6% vs 16% of total marketing budgets). This is in stark contrast to other industries, where spending on multichannel initiatives is already well over 20% and set to increase by 10% in 2014.
COVID-19: How Businesses are Handling the CrisisPaul Merchan
The Institute of Public Relations (IPR) and Peppercomm teamed up to produce a survey of 300 communications executives and senior business leaders to gauge how prepared they are for COVID-19 (novel coronavirus) and how they are communicating about it.
When it comes to engaging with your customers, do you have the right formula to reach them through their CHANNEL of preference, with the CONTENT they want and at their CONVENIENCE ? How engaged is your brand?
This year, Alterian surveyed nearly 1,500 marketing professionals to see just where brands stand when it comes to expenditure, social media, level of personalization, and whether brands are ready for growth or at risk.
In this presentation Donnell Wright and Russ Taufa, of Alterian's research consulting group, examine survey findings and provide insight into how brand engagement is shifting as well as discuss new marketing opportunities for 2011.
지난 2013년 6월 “Digital Health: Building Social Confidence in Pharma’라는 제목으로 웨버 샌드윅(Weber Shandwick)이 발표한 리포트는 현재 글로벌 제약회사에서 소셜 미디어 커뮤니케이션 활동을 책임지는 13명의 임원들과 마케팅 컨설턴트가 참여했으며, 제약회사들의 소셜 미디어 도입 현황, 도입 시 혜택, 극복과제, 실행 방안 등 주제별 주요 인사이트가 반영되어 있다.
Empowering patients and health professionals through digital contentVanksen
From the innovations developed by international laboratories (use of AI and machine learning, biopharma, digital health…) to the latest international reforms designed to widen the access to care, all arrows point to the same direction: health has become an increasingly important topic, and even more so since the pandemic.
Vanksen’s experts zoomed in to try and understand the ways in which digital levers can empower pharma players around the world.
Experience taught us that marketing and communication have different rules if you are the CDO or CMO of a European lab. It is strictly forbidden to target patient audiences with content advertising subscription medication. So, what can they do?
https://www.vanksen.com/en/insights/empowering-patients-health-professionals-through-digital-content
Similar to It's 2018, Should US Pharma still be Scared of Digital? (20)
Infographics of The Big 5 Tech Giants recent Digital Health Journey's (Amazon, Apple, Facebook, Google and Microsoft). Hyperlinks to all Digital Health news content at each milestone. Presentation is downloadable and should be a useful reference
A 3+ Year Review of 12 StartUp Health Companies ProgressGary Monk
On 10/26/15 I met 12 StartUp Health companies at the Cleveland Clinic. This annotated presentation shows where these companies are today in terms of activity and funding status. Some encouraging reading (See slide 15 summary)
85% of clinical trials fail to recruit enough patients, 80% fail to finish on time. A key issue is 70% of patients live more that 2 hours from the study site. Wearable devices can support the collection of real world data in the patients home as well as create novel endpoints
Its 2019 - Should Pharma Still Be Scared of Digital?Gary Monk
Updated deck with 2018 ABPI data on UK breaches to the code of practice by Pharma and how much of role did digital play?
One of Pharma's biggest fears when it comes to adopting digital and new technology, is fear of regulations and compliance. To see how much of an issue this really is, breaches of the ABPI code of practice were analyzed over 2017 & 2016, across all channels. The results are interesting...
An Analysis of the Mobile Search Habits of Americans. What are the proportion of searches performed on mobile devices across the most popular categories? How does healthcare and pharma stack up in terms of consumers searching on mobile?
Mobile Searches in Healthcare - 2018 UPDATEGary Monk
An updated and annotated presentation of analysis of mobile searches in healthcare across a range of medical conditions. The findings show a significant increases across the board, over the last 3 years and some interesting findings. The original presentation had over 2000 views
Its 2018... Should Pharma Still be Scared of Digital?Gary Monk
One of Pharma's biggest fears when it comes to adopting digital and new technology, is fear of regulations and compliance. To see how much of an issue this really is, breaches of the ABPI code of practice were analyzed over 2017 & 2016, across all channels. The results are interesting...
Virtual and Augmented Reality in HealthcareGary Monk
An overview of some of the latest examples of where Virtual Reality, Augmented Reality and Mixed Reality are impacting healthcare in a dramatic way. There are numerous examples across a range of conditions.
Note: A number of these examples are featured in more detail in the health section of the following book:
The Fourth Transformation: How Augmented Reality & Artificial Intelligence Will Change Everything (Scoble & Israel)
Wikipedia Health Landscape - Top Health ConditionsGary Monk
This is an update of research into a previous SlideShare looking at the use of Wikipedia to research health conditions and diseases. There is also an interview with top Wikipedia editor Dr James Heilman
Technology versus Cancer (How can technology help?)Gary Monk
There is a lot of cancer ‘moonshotting’ going on but what are the main ways that technology can help the fight against cancer?
This presentation is focused on how technological hardware, software, data, algorithms, artificial intelligence and wearables can help win the war against cancer. Emerging technology promises so much particularly when it comes to the battle against cancer.
Top 10 Health Trends at CES 2016 - Havas HealthGary Monk
The Top 10 health related trends at CES 2016. The trends are wide ranging from Fitness to Automotive This deck gives you the health trends to watch, with some specific future use cases and some that are very relevant now. For questions, more information or discussion please get in touch!
Health Tech & Health Care - A Shiny Future? Gary Monk
Health innovations including wearables, sensors, big data analytics and 'behavior changing' applications and devices are ubiquitous. These technologies promise so much yet are they really benefiting the healthcare consumer? And what does the future look like? This presentation highlights some real world examples of this technology in use today and some insights into what the future may hold. This presentation on Health Technology was presented at the @BrightTALK event on 10th Dec. 2015
Highlights of some key sessions I attended at SXSW 2015. The bias is towards innovation and healthcare. How to set up your business for success, think differently, leverage new technology and engage your customers.
My personal selection of highlights from the #ePharma 2015 summit in NYC. The topics ranged from wearables to innovation to population health and emerging pharma business models. The highlights are from 25-26 Feb 2015
18 Interesting Health Technology StartupsGary Monk
An overview of 18 interesting health technology startups. Some are more successful than others, some are in a relatively crowded space. Slides contain an overview and insights into these emerging healthtech companies
Consumer Electronics Show 2015 - A healthcare summaryGary Monk
A summary of the latest health technology, advances in remote medicine and pharma cases from the 2015 Consumer Electronics Show (CES) in Las Vegas. Outputs from the health exhibition and digital health sessions
Analysis in the rise of mobile search in Healthcare and Pharma over the last 2 years. All analysis via google, over the last 8 quarters. Trends across 10 interesting and common diseases are analyzed.
Wikipedia Pharma Disease Analysis in EU5 CountriesGary Monk
Wikipedia Pharma Disease Analysis in EU5 Countries (Spanish, German, French, English, Italian. A review of the most viewed disease pages in English and a comparison with the other languages. The analysis looks at relative page views for the Top 5 diseases and how active the editors are, with recommendations for healthcare companies considering editing.
An analysis of Pharma Wikipedia disease pages. This looks at the common pharma disease pages on Wikipedia, including how often they are viewed and edited. It analyses the top editors of these disease pages that are of interest to Pharma companies. Editing disease pages by Pharma companies, in the right way, is a potentially lower risk route than prescription medicine pages. This is a useful analysis for anyone working in healthcare and interested in editing Wikipedia.
LGBTQ+ Adults: Unique Opportunities and Inclusive Approaches to CareVITASAuthor
This webinar helps clinicians understand the unique healthcare needs of the LGBTQ+ community, primarily in relation to end-of-life care. Topics include social and cultural background and challenges, healthcare disparities, advanced care planning, and strategies for reaching the community and improving quality of care.
KEY Points of Leicester travel clinic In London doc.docxNX Healthcare
In order to protect visitors' safety and wellbeing, Travel Clinic Leicester offers a wide range of travel-related health treatments, including individualized counseling and vaccines. Our team of medical experts specializes in getting people ready for international travel, with a particular emphasis on vaccines and health consultations to prevent travel-related illnesses. We provide a range of travel-related services, such as health concerns unique to a trip, prevention of malaria, and travel-related medical supplies. Our clinic is dedicated to providing top-notch care, keeping abreast of the most recent recommendations for vaccinations and travel health precautions. The goal of Travel Clinic Leicester is to keep you safe and well-rested no matter what kind of travel you choose—business, pleasure, or adventure.
About this webinar: This talk will introduce what cancer rehabilitation is, where it fits into the cancer trajectory, and who can benefit from it. In addition, the current landscape of cancer rehabilitation in Canada will be discussed and the need for advocacy to increase access to this essential component of cancer care.
International Cancer Survivors Day is celebrated during June, placing the spotlight not only on cancer survivors, but also their caregivers.
CANSA has compiled a list of tips and guidelines of support:
https://cansa.org.za/who-cares-for-cancer-patients-caregivers/
This document is designed as an introductory to medical students,nursing students,midwives or other healthcare trainees to improve their understanding about how health system in Sri Lanka cares children health.
TEST BANK For Accounting Information Systems, 3rd Edition by Vernon Richardso...rightmanforbloodline
TEST BANK For Accounting Information Systems, 3rd Edition by Vernon Richardson, Verified Chapters 1 - 18, Complete Newest Version
TEST BANK For Accounting Information Systems, 3rd Edition by Vernon Richardson, Verified Chapters 1 - 18, Complete Newest Version
TEST BANK For Accounting Information Systems, 3rd Edition by Vernon Richardson, Verified Chapters 1 - 18, Complete Newest Version
We are one of the top Massage Spa Ajman Our highly skilled, experienced, and certified massage therapists from different corners of the world are committed to serving you with a soothing and relaxing experience. Luxuriate yourself at our spas in Sharjah and Ajman, which are indeed enriched with an ambiance of relaxation and tranquility. We could confidently claim that we are one of the most affordable Spa Ajman and Sharjah as well, where you can book the massage session of your choice for just 99 AED at any time as we are open 24 hours a day, 7 days a week.
Visit : https://massagespaajman.com/
Call : 052 987 1315
Under Pressure : Kenneth Kruk's StrategyKenneth Kruk
Kenneth Kruk's story of transforming challenges into opportunities by leading successful medical record transitions and bridging scientific knowledge gaps during COVID-19.
PET CT beginners Guide covers some of the underrepresented topics in PET CTMiadAlsulami
This lecture briefly covers some of the underrepresented topics in Molecular imaging with cases , such as:
- Primary pleural tumors and pleural metastases.
- Distinguishing between MPM and Talc Pleurodesis.
- Urological tumors.
- The role of FDG PET in NET.
DECODING THE RISKS - ALCOHOL, TOBACCO & DRUGS.pdfDr Rachana Gujar
Introduction: Substance use education is crucial due to its prevalence and societal impact.
Alcohol Use: Immediate and long-term risks include impaired judgment, health issues, and social consequences.
Tobacco Use: Immediate effects include increased heart rate, while long-term risks encompass cancer and heart disease.
Drug Use: Risks vary depending on the drug type, including health and psychological implications.
Prevention Strategies: Education, healthy coping mechanisms, community support, and policies are vital in preventing substance use.
Harm Reduction Strategies: Safe use practices, medication-assisted treatment, and naloxone availability aim to reduce harm.
Seeking Help for Addiction: Recognizing signs, available treatments, support systems, and resources are essential for recovery.
Personal Stories: Real stories of recovery emphasize hope and resilience.
Interactive Q&A: Engage the audience and encourage discussion.
Conclusion: Recap key points and emphasize the importance of awareness, prevention, and seeking help.
Resources: Provide contact information and links for further support.
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Guillermo Rivera
This conference will delve into the intricate intersections between mental health, legal frameworks, and the prison system in Bolivia. It aims to provide a comprehensive overview of the current challenges faced by mental health professionals working within the legislative and correctional landscapes. Topics of discussion will include the prevalence and impact of mental health issues among the incarcerated population, the effectiveness of existing mental health policies and legislation, and potential reforms to enhance the mental health support system within prisons.
Chandrima Spa Ajman is one of the leading Massage Center in Ajman, which is open 24 hours exclusively for men. Being one of the most affordable Spa in Ajman, we offer Body to Body massage, Kerala Massage, Malayali Massage, Indian Massage, Pakistani Massage Russian massage, Thai massage, Swedish massage, Hot Stone Massage, Deep Tissue Massage, and many more. Indulge in the ultimate massage experience and book your appointment today. We are confident that you will leave our Massage spa feeling refreshed, rejuvenated, and ready to take on the world.
Visit : https://massagespaajman.com/
Call : 052 987 1315
INFECTION OF THE BRAIN -ENCEPHALITIS ( PPT)blessyjannu21
Neurological system includes brain and spinal cord. It plays an important role in functioning of our body. Encephalitis is the inflammation of the brain. Causes include viral infections, infections from insect bites or an autoimmune reaction that affects the brain. It can be life-threatening or cause long-term complications. Treatment varies, but most people require hospitalization so they can receive intensive treatment, including life support.
It's 2018, Should US Pharma still be Scared of Digital?
1. Its 2018…Should US Pharma
still be scared of Digital?
Gary Monk
March 5, 2018
2. Introduction
• This is a follow up to my recent popular post about UK pharma, an
analysis to see what the situation is on the other side of the pond
• The biggest barrier to digital adoption in Pharma is ‘Regulatory,
legal and health care compliance issues'
• How grounded in reality is this fear? When Pharma 'do digital'
do things go wrong? And if so why?
• To answer the above for US Pharma I analyzed over 100 FDA,
Office of Prescription Drug Promotion (OPDP) warning letters
spanning the last 7 years, identifying the ‘guilty’ marketing
channel (Via which misleading or a lack of fair & balanced
information was disseminated)
3. 10
20
30
40
2011 2012 2013 2014 2015 2016 2017
31
28
24
9 9
11
5
In the last 7 years (2011 to 2017)
The FDA issued 117 OPDP warning letters
There has been a downward
trend in warning letters issued
Does this mean Pharma are
becoming more compliant in all
communications OR that the
FDA are deploying less
resources?
Number of warning letters per year
4. Number of
warning letters
(2011-2017)23
11
80
In these 7 years
96 different Pharma companies received an
FDA OPDP letter
Does this mean Pharma take the FDA letter
seriously and change behavior OR that the
FDA is simply spread too thin?
One
Two
Three
Four
Number of companies per number of letters
The vast majority of companies had only
one breach with a few ‘repeat offenders’, one
company having four over the period
6. Non-Digital
95%
Social Media
5%
And of these 127 channels, only 6 related
to social media (5%)
Percentage of social media / non social-media channels implicated
by FDA, OPDP letters
• 4 were on You Tube, purely the video content
and not any comments of social posts
• 1 was on Facebook, related to content on the
page description, not any posts by the
company or users that could have been
deemed misleading
• Only 1 was related to social content of a
dynamic nature, Instagram use by a celebrity
endorser (The Kim Kardashian post)
7. 18%
35%
53%
70%
2011 2012 2013 2014 2015 2016 2017
26%
42%
36%
44%
56%
64%
43%
The percentage of warning letters relating to
digital channels appears to be increasing
There is an upward trend in
letters relating to digital
suggesting Pharma are getting
stuck in and making some
mistakes along the way?
A caveat is a potential lack of
statistical significance, with the
relatively low number of letters
per year, e.g. only 5 in 2017
Number of warning letters per year related to digital channels
26%
42%
36%
44%
56%
64%
43%
8. Website
60%
Social Media
12%
Video Content
12%
Email - HCP
6%
Podcast
2%
Online Brochure
2%
3rd Party Website
2%
Search Ad
2%
Banner Ad
2%
But the majority of warning letters sent relate
to websites suggesting a lack of innovation?
But many US Pharma co’s are clearly
working with social media, creating and
managing their own Facebook pages and/or
using paid posts, meaning:
In these cases Pharma are either delivering
these initiatives compliantly (as there are so
few warnings)
OR - The FDA have not been able to keep up
with ‘policing’ these initiatives / their focus is
on other ‘core’ channels
Percentage of types of digital channels implicated by FDA, OPDP
letters 2011-2017
9. NO
94%
YES
6%
And of these 50 digital channels, only 3 (5%)
were possibly related to the complexity around
digital
Was the issue leading to the FDA letter ‘possibly’ related to digital
complexity?
The vast majority of issues related to digital
channels were because of misleading
content, e.g. on a webpage, where there
were no issues related to space.
The 3 breaches possibly related to space
and the companies failing to incorporate
drug safety / risk information were:
• The Kim Kardashian Instagram / Twitter
post
• One example of a banner ad
• One example of a search ad
10. The non-digital issues leading to warning
letters all related to misleading content
The fundamental issue Pharma
face is ensuring they provide
fair, balanced and accurate
information. It has little if
anything to do with digital vs
non-digital or the type of
channel employed
The ‘top’ digital channels implicated in FDA OPDP warning letters
(2011-2017)
Rep Detail
Print Mailing
Exhibition Stand
Leavepiece HCP
Patient Brochure
0 4 8 12 16
11. So what is going on here?
• Pharma are either mostly compliant in digital OR
The FDA are under resourced / not focusing their
resources on digital (based on the relatively low
number of warning letters issued)
12. Looking at the FDA priorities their focus
is more ‘traditional’
• The FDA’s core focus is not digital, for voluntary submission they require the
following categories
• ‘Comprehensive Labeling piece’ directed at professionals, e.g. detail aid or
exhibition panel
• An Advertisement to professionals, e.g. journal ad
• One comprehensive DTC Labeling piece e.g. Patient brochure
• One DTC advertisement e.g. Magazine Ad
• A professional and/or DTC Website
This would explain the FDA’s focus on these categories. Over 50% of the
letters issued cover these above areas Of course websites are ‘digital’ but
rarely complex or innovative
13. I asked the FDA for some feedback
• I was told “The FDA does not provide comment on its internal processes or
on external presentations and articles”
• However they kindly provided additional background on the FDA’s oversight
program, which actually gives a good perspective
(The full communication is on the next two slides, I have simply taken the
liberty to split into the digestible chunks)
14. Feedback from the FDA (1 of 2)
• "Issuing warning letters is just one component of the FDA’s multi-faceted
program for the oversight of industry’s promotion of FDA-regulated medical
products. We have many efforts to encourage compliance by industry,
including our work on Guidances, providing advice to companies on draft
promotional materials, and outreach to our stakeholders”
• "The FDA’s priorities regarding prescription drug promotion are; policy and
guidance development, labeling reviews, core launch and TV ad reviews,
training and communications, and enforcement”
• "The FDA uses a risk-based approach to carefully allocate its resources
among these activities to have the greatest beneficial public health impact.
Therefore, one cannot get a complete picture of the FDA’s program area by
looking at a snapshot of time for warning letters"
15. Feedback from the FDA (1 of 2)
• "Reviewing the number of warning letters that the FDA issues on a particular
topic within a year timeframe does not take into account the work that the
FDA does on the other priorities to assist companies with compliance, such
as policy and guidance development and core launch reviews, to fulfill its
public health mission”
• "To help increase voluntary compliance, the FDA continues to devote
additional resources to its work on Guidances and providing advice to
companies for draft promotional materials, where appropriate"
16. Summary
• It is true this research is narrow, however it is focused on the area
Pharma fear most, being found in breach of the FDA regulations,
the enforcement piece
• The FDA’s focus is broad and proactive, trying to prevent
companies breaking the rules in the first place. This research
supports that approach. I would not recommend that the FDA hire
a bunch more people to focus on ‘digital compliance’ because…
• Digital channels are not the problem, it is Pharma internal
processes and culture that lead to the dissemination of
misinformation, regardless of the medium used (exactly as in my
recent UK analysis)
17. Don’t be scared, say hello!
@garymonk
linkedin.com/in/garywmonk/